Company reports third death in SL-401 trialFebruary 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
OS is worse with refractory vs relapsed PTCLFebruary 3, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Therapy granted PIM designation for CTCLFebruary 3, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Kids, parents over-report ALL treatment adherenceFebruary 3, 2017Leukemia, Myelodysplasia, TransplantationHematology NursingPediatricsALL
Company withdraws MAA for pegfilgrastim biosimilarFebruary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Cheap manufacture of generic cancer drugs is feasible, study showsFebruary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology NursingPediatricsPharmacyRelated Issues
Regimens seem similarly effective in ENKTLFebruary 2, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Group proposes new prognostic model for PTCL-NOSFebruary 1, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Project provides insight into T-cell lymphomaFebruary 1, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Recent price hikes for generic cancer meds exceed 100%February 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues